Comparative analysis of neurofilament light chain in Huntington's disease like 2 and Huntington's disease
Journal of Huntington's Disease · 2025
DOI: 10.1177/18796397241300141 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Huntington's Disease, 2025. Verfasst von David G Anderson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital and University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Huntington Disease, Neurofilament Proteins. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Huntington's disease-like 2 (HDL2) closely resembles Huntington's disease (HD) in clinical and pathological features. Neurofilament light chain (NfL) is an important biomarker in HD research and holds potential in HDL2. To evaluate NfL's utility in HDL2, a comparative analysis among HDL2 (n = 12), HD (n = 9), and unaffected controls (n = 9) was conducted. Employing a cross-sectional design, NfL levels were assessed in blood plasma. Concentrations were notably elevated in both HD and HDL2 groups compared to controls. HD patients displayed higher NfL levels than HDL2, possibly reflecting disease duration differences. NfL effectively distinguished HDL2 from controls, highlighting its promise as a possible biomarker in HDL2 research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital and University of Glasgow, Glasgow, UK.
- Division of Human Genetics, National Health Laboratory Service and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Department of Psychology, School of Human and Community Development, University of the Witwatersrand, Johannesburg, South Africa.
- UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.
- Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
- Instituto de Medicina Molecular João Lobo Antunes, Lisbon, Portugal.
ORCID-Profile: David G Anderson, Aline Ferreira-Correia, Filipe B Rodrigues, Lauren M Byrne, Amanda Krause
Zitieren
APA
Anderson, D. G., Ferreira-Correia, A., Rodrigues, F. B., Byrne, L. M., Wild, E. J., & Krause, A. (2025). Comparative analysis of neurofilament light chain in Huntington's disease like 2 and Huntington's disease. Journal of Huntington's Disease. https://doi.org/10.1177/18796397241300141
Vancouver
Anderson DG, Ferreira-Correia A, Rodrigues FB, Byrne LM, Wild EJ, Krause A. Comparative analysis of neurofilament light chain in Huntington's disease like 2 and Huntington's disease. Journal of Huntington's Disease. 2025. doi:10.1177/18796397241300141
BibTeX
@article{Anderson2025,
author = {Anderson, David G and Ferreira-Correia, Aline and Rodrigues, Filipe B and Byrne, Lauren M and Wild, Edward J and Krause, Amanda},
title = {Comparative analysis of neurofilament light chain in Huntington's disease like 2 and Huntington's disease},
journal = {Journal of Huntington's Disease},
year = {2025},
doi = {10.1177/18796397241300141}
}
EUVIMED